Posted On: 08/15/2013 10:47:38 AM
Post# of 5066
Re: patientgal #2492
PG,
Let's say the FDA finally agrees to approve the IND and BMSN is free and clear to start P1 trials for HEmaxellerate. Where does BMSN get the money to do the trials? Will it come from that 20million in financing that was done a while back? And if bmsn doesn't get orphan status, will that 20MM be enough to cover p2 trials? Or do you think if P1 is successful and meets all its endpoints that there is some sugar daddy in the wings to come in and fund p2 trials?
Let's say the FDA finally agrees to approve the IND and BMSN is free and clear to start P1 trials for HEmaxellerate. Where does BMSN get the money to do the trials? Will it come from that 20million in financing that was done a while back? And if bmsn doesn't get orphan status, will that 20MM be enough to cover p2 trials? Or do you think if P1 is successful and meets all its endpoints that there is some sugar daddy in the wings to come in and fund p2 trials?
(0)
(0)
